VERICEL CORP
Vericel (formerly Aastrom Biosciences) is developing patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions. Aastrom markets two autologous cell therapy products in the United States for the treatment of cartilage repair and skin replacement. Aastrom is also developing MACI™, a third-generation autologous chondrocyte implantation product for the treatment of focal chondral cartilage defects in the knee, and ixmyelocel-T, a patient-specific multicellular therapy for the treatment of advanced heart failure due to ischemic dilated cardiomyopathy.
VERICEL CORP
Industry:
Biotechnology Life Science Therapeutics
Founded:
1989-01-01
Address:
Ann Arbor, Michigan, United States
Country:
United States
Website Url:
http://www.vcel.com
Total Employee:
251+
Status:
Active
Contact:
(617)588-5555
Email Addresses:
[email protected]
Total Funding:
157.3 M USD
Technology used in webpage:
Amazon Amazon Virginia Region IIS Sectigo SSL Amazon S3 CDN Sectigo Domain SSL Invalid Certificate Dates IIS 8 New Relic Akamai Hosted
Similar Organizations
Akebia Therapeutics
Akebia Therapeutics develops treatments for ischemia and vascular diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Berni Labs
Berni Labs is dedicated to the development of formulations from plant extracts.
Proclara Biosciences
Proclara is pioneering a new approach to treating neurodegenerative diseases.
Renovacor
Renovacor is a biopharmaceutical company that focuses on developing transformative gene therapy‑based treatments for cardiovascular disease.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Eastern Capital
Eastern Capital investment in Post-IPO Equity - Vericel Corp
Key Employee Changes
| Date | New article |
|---|---|
| 2024-07-22 | Vericel Announces Appointment of Karen Mahoney as Chief Human Resources Officer |
| 2022-02-24 | Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer |
Official Site Inspections
http://www.vcel.com Semrush global rank: 5.34 M Semrush visits lastest month: 1.43 K
- Host name: 104.26.15.20
- IP address: 104.26.15.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vericel Corp"
Vericel Corporation | Advanced cell therapies
Nov 25, 2024 Vericel manufactures and markets two advanced cell therapy products for sports medicine and severe burn care in the United States and holds an exclusive license for North American commercial rights to NexoBrid ®, a …See details»
Vericel Corp - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number (617)588-5555 Vericel (formerly Aastrom Biosciences) is developing patient-specific expanded cellular therapies for use in the treatment …See details»
2021 - vcel.com
2022 Proxy Statement, our 2021 Annual Report, and additional information at www.vcel.com. Forward-Looking Statements All statements other than statements of historical facts included …See details»
Vericel Company Profile | Management and Employees List
SQL International Organization for Standardization . HTML Web Hypertext Application Technology Working Group . PHP PHP . CSS World Wide Web Consortium . Enterprise …See details»
Vericel Corporation (VCEL) Company Profile & Facts - Yahoo Finance
See the company profile for Vericel Corporation (VCEL) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
Vericel - Overview, News & Similar companies | ZoomInfo.com
On July 12, 2024, Mara Joseph Anthony Jr, Chief Financial Officer of Vericel Corp (NASDAQ:VCEL), executed a sale of 5,000 shares of the company at a price of $50 per share. …See details»
Vericel Corporation (VCEL) - Yahoo Finance Canada
Vericel Corporation (VCEL) Follow. Compare. 56.52-1.63 (-2.80%) At close: December 5 at 4:00:00 p.m. EST . 62.99 +6.47 (+11.45%) Pre-Market: 4:08:54 a.m. EST . Key Executives . …See details»
Investor FAQs - Vericel Corporation
The symbol is VCEL. Where are Vericel Corporation's headquarters located? Headquarters: Vericel Corporation 64 Sidney Street Cambridge, MA 02139 Phone: (617) 252-7999 Fax: …See details»
VCEL | Vericel Corp. Profile - MarketWatch
VCEL Profile. Company Profile. Vericel Corp. 64 Sidney Street. Cambridge, Massachusetts 02139-4170 . Phone 1 617 588-5555. Industry Biotechnology; Sector Health Care/Life …See details»
Vericel Announces Appointment of Jonathan Siegal as Principal ...
The company s accounting function and served as a leader across the financial organization. Prior to joining Lantheus in 2016, he served in a number of accounting and controllership roles of …See details»
Vericel Corporation (VCEL) - Yahoo Finance
Find the latest Vericel Corporation (VCEL) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Investor Relations - investors.vcel.com
Nov 6, 2019 In that capacity, Mr. Flynn handled a wide assortment of business and legal matters for the organization, while maintaining responsibility for the compliance readiness of the …See details»
Vericel Corporation (VCEL) Stock Price, Quote & News - Stock …
4 days ago About VCEL. Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for …See details»
Vericel Corporation (VCEL) - Yahoo Finance
Vericel Corp. (VCEL) Cooled Down in Q3 After a 20% Rise in the First Half. Conestoga Capital Advisors, an asset management company, released its third-quarter 2024 investor letter.See details»
Vericel Reports Fourth Quarter and Full-Year 2023 ... - Vericel …
CAMBRIDGE, Mass., Feb. 29, 2024 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn …See details»
Vericel Corporation | Advanced Therapies
4 days ago Indication and Important Safety Information Indication. MACI ® (autologous cultured chondrocytes on porcine collagen membrane) is an autologous cellularized scaffold product …See details»
Vericel (VCEL) Earnings Date and Reports 2025 - MarketBeat
3 days ago Vericel (NASDAQ:VCEL) has a trailing price-to-earnings ratio of 957.99 and a forward price-to-earnings ratio of 442.08. What is Vericel's EPS forecast for next year? …See details»
Vericel Corporation | Clinical Development
Feb 21, 2024 Now recruiting for Clinical Trial PEAK (55-1702-1). PEdiatric Autologous cultured chondrocytes treatment of cartilage defects in the Knee: A Study of MACI in Patients Aged 10 …See details»
Vericel Corporation | Careers
Join Our Team. Vericel is an innovative company committed to improving the lives of patients with serious conditions through the development and manufacture of unique advanced cell …See details»